Enhancing radiosensitivity: Targeting the DNA repair pathways

 Abstract

Radiotherapy is very effective in local control of cancerous tumors, but its curative potential is often
limited by intrinsic radioresistance of the tumor cells. Since DNA repair pathways remove radiation-
induced DNA lesions and protect cells from lethality, these pathways represent potential therapeutic
targets to radiosensitize tumors. In order to achieve a therapeutic gain, however, there must be a
differential between tumor and normal cells that can be exploited to preferentially target the DNA repair
of the tumor, while sparing surrounding normal tissues, and this has represented a significant challenge
to progress. Nevertheless, recent advances in our understanding of DNA repair mechanisms and tumor
biology, on both the biochemical and genetic levels, have identified molecular differentials that may
increase tumor specificity. This mechanistic insight suggests new strategies for radiotherapeutic
targeting of DNA repair. Some of these strategies are reviewed here, including synthetic lethal,
replicative stress, cell cycle, and hypoxia-based approaches. The example of PARP1 inhibitor use in
BRCA 1 and 2 mutated breast cancer therapy is discussed, and future directions and challenges are
explored.

Full Text Options
Article
Metrics
 Share
 Info
Pages
665 - 670
doi
10.4161/cbt.8.8.8304
Type
Review
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Enhancing radiosensitivity: Targeting the DNA repair pathways